Scientists are cautioning against the reliance on hydroxychloroquine in Djibouti‘s management of the coronavirus even though the small African country has seen improved recoveries.
Speaking to the VOA, Sultan Ayoub Meo, a clinical physiologist at King Saud University in Saudi Arabia, said although recent peer-reviewed studies have spoken to the efficacy of hydroxychloroquine as well as chloroquine, there is a need to be cautious.
This relative success has been down entirely to the administration of hydroxychloroquine, according to Djibouti’s head of COVID-19 response center.
In spite of this, the WHO’s representative in Djibouti says “until today do not have evidence that it (the drug) is something that is functional” against the coronavirus.
Mauritius, Mauritania and, Morocco are three other countries on the continent that have seen some success with using hydroxychloroquine, with the first two countries at some points recording zero new coronavirus infections over weeks.
